XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
REVENUES $ 360,815 $ 222,204 $ 1,099,980 $ 518,272
OPERATING EXPENSES:        
Production costs 434,225 396,301 1,315,350 846,338
Exploration costs 47,866 56,909 175,715 144,588
General and administrative 443,503 501,178 1,244,975 1,936,301
Total Operating Expenses 925,594 954,388 2,736,040 2,927,227
Operating Loss (564,779) (732,184) (1,636,060) (2,408,955)
OTHER INCOME (EXPENSES):        
Interest expense, net (including amortization of deferred financing cost and debt discount) (474,579) (463,462) (1,401,878) (1,363,330)
Change in fair value   (23,000) 0 (23,000)
Gain on forgiveness of PPP loan     223,075 0
Other income, net 20,308 54,855 114,662 1,355,205
Total Other (Expenses) (454,271) (431,607) (1,064,141) (31,125)
NET LOSS (1,019,050) (1,163,791) (2,700,201) (2,440,080)
Deemed dividend on Series B Convertible preferred stock (112,525) (23,187) (225,137) (23,187)
Net Loss Attributable to Common Shareholders $ (1,131,575) $ (1,186,978) $ (2,925,338) $ (2,463,267)
Net Loss Per Common Share (Basic and Diluted) $ (0.01) $ (0.01) $ (0.02) $ (0.01)
Weighted Average Common Shares Outstanding (Basic and Diluted) 199,138,961 175,638,549 194,202,348 175,616,195